Walleye Trading
XTNT icon

Walleye Trading’s Xtant Medical Holdings XTNT Stock Holding History

Walleye Trading’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-35
Closed -$1K – 5782
2016
Q1 		$1K Buy
35
+10
+40% +$319 ﹤0.01% 5203
2015
Q4 		$1K Buy
+25
New +$879 ﹤0.01% 5165

Other funds holding XTNT

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Trading's XTNT Position: Q2 2016 in Review

Walleye Trading sold out of Xtant Medical Holdings (XTNT) in Q2 2016, closing a stake of 35 shares — an estimated $1K sold.

Walleye Trading first reported a position in XTNT in Q4 2015 and held it in 2 quarters. The position peaked at $1K in Q1 2016. 17 funds tracked by Wall St. Rank hold XTNT as of Q2 2016.

  • Walleye Trading reported no remaining Xtant Medical Holdings position as of Q2 2016 after selling out during the quarter.
  • Walleye Trading sold 35 Xtant Medical Holdings shares in Q2 2016, an estimated $1K.
  • Walleye Trading first reported a position in Xtant Medical Holdings in Q4 2015 and held it in 2 quarters.
  • Walleye Trading's Xtant Medical Holdings position peaked at $1K in Q1 2016.
  • 17 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2016.

Based on Walleye Trading's 13F filing for Q2 2016, filed 15 Aug 2016.